Цитрамон-Боримед

Quick links

Choose a section

Quick links to important sections

Advertisements

Цитрамон-Боримед

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Цитрамон-Боримед

What is Цитрамон-Боримед? (E-E-A-T Optimized Overview)

Property Description
Active Ingredients Acetaminophen, Acetylsalicylic Acid, Caffeine
Form Tablet (Solid Oral Preparation)
Pharmacological Class Analgesic-Antipyretic Combination
Common Use Symptomatic relief of pain and fever
Origin Synthetic Compounds
OTC Status Over-the-counter (OTC) medicine

What is Цитрамон-Боримед and its Pharmacological Type?

Цитрамон-Боримед is a specific fixed-dose combination (FDC) medicine generally available as an over-the-counter (OTC) product. It is classified within the analgesic-antipyretic pharmacological group and is supplied as a tablet for oral administration. This structural design ensures the systemic delivery of three distinct compounds simultaneously, a method that is recognized for improving patient compliance and simplifying acute pain management. The active components are derived through chemical synthesis, establishing the product as being of synthetic origin.

Composition: The Three Active Components

The formulation is characterized by three essential active ingredients: Acetaminophen (an anilide derivative), Acetylsalicylic Acid (ASA) (a non-steroidal anti-inflammatory drug or NSAID), and Caffeine (a xanthine derivative). The rationale for this FDC is based on combining the centrally-acting analgesic with the peripherally-acting NSAID and the psychostimulant to achieve enhanced pain modulation. This means the presence of caffeine makes the resulting pain relief consistently more effective compared to the analgesics used individually.

General Purpose: Symptomatic Relief Function

The fundamental purpose of this medicine is to provide effective symptomatic relief, particularly in scenarios such as typical tension-type headache or during periods of elevated body temperature, demonstrating both analgesia (pain relief) and antipyresis (fever reduction). The FDC operates with synergistic efficacy, meaning the collective therapeutic effect on pain signaling is greater than the sum of the components’ individual actions. This multi-component preparation is utilized for addressing acute discomfort where combined antipyretic and potent analgesic effects are required.

Regulatory References

  1. Acetaminophen/Aspirin/Caffeine Combination - StatPearls - NCBI Bookshelf
Advertisements

What side effects are possible with Цитрамон-Боримед?

Possible Side Effects and Safety Information

The safety profile of this fixed-dose combination (Acetaminophen, Acetylsalicylic Acid, Caffeine) is structured by the known risks of its active components, as defined in official regulatory documents. Adverse reactions are grouped by frequency and the body systems affected (System-Organ Classes, SOC).

Frequency-Classified Adverse Reactions

Classification Examples of Documented Effects
Common Nervousness, Insomnia, Dizziness, Dyspepsia, Nausea, Abdominal pain
Rare Tachycardia, Vertigo, Gastrointestinal ulcers and bleeding, Diarrhea
Very Rare Severe skin reactions (SJS, TEN), Serious blood disorders (Agranulocytosis)

Serious Adverse Reactions and Key Constraints

The most serious documented safety risks are linked to the two analgesic components. The regulatory labels highlight the risk of severe hepatotoxicity (liver damage/failure) due to the Acetaminophen component, and serious gastrointestinal bleeding (hemorrhage and perforation) due to the Acetylsalicylic Acid component. Severe allergic reactions and Reye's Syndrome (in children/teenagers recovering from viral illness) are also documented concerns.

Specific population-based constraints are defined. The medicine is contraindicated in the third trimester of pregnancy, in pediatric patients recovering from viral illness, and in individuals with severe hepatic or renal impairment. Furthermore, regulatory documents warn that using this combination for 10 or more days per month may lead to Medication Overuse Headache (MOH).

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for an overdose of this combined medicine highlights the risk of severe, delayed, and acute multi-system toxicity. Documented overdose presentations may include gastrointestinal effects (nausea, vomiting), signs of CNS stimulation (tremor, agitation), and early indicators of salicylate toxicity, such as tinnitus and hyperventilation.

The physiological systems affected are primarily the hepatic system, with risk of delayed fatal necrosis from the acetaminophen component, and the acid-base balance, with potential for profound metabolic acidosis from the acetylsalicylic acid. Patients with pre-existing hepatic or renal impairment have a documented increased susceptibility to severe outcomes.

Immediate medical attention is mandated for any suspected overdose, even if the patient initially appears asymptomatic, due to the time-critical nature of interventions. Specific antidotal treatment with N-acetylcysteine is required to manage the acetaminophen component. Management procedures described in official documents include the use of activated charcoal, correction of fluid and electrolyte imbalances, and specialized treatments like urine alkalinization or hemodialysis to address systemic disturbances. Hospital observation is required for monitoring and is critical for assessing the potential for delayed complications like hepatic necrosis.

Advertisements

Therapeutic Uses of Цитрамон-Боримед

Main Uses and Benefits of Цитрамон-Боримед

The primary therapeutic role of this combination medicine plays a role in managing symptoms related to physical discomfort across multiple domains of discomfort that may appear suddenly or intensify over time. The medication is utilized for easing mild to moderate intensity pain and fever syndrome in a variety of **conditions presenting with systemic or localized discomfort.

The benefit may be considered primarily supportive. This medicine is commonly used to help with acute symptomatic episodes involving headache pain, the acute symptomatic phase of migraine attacks, fever associated with infectious conditions, and localized pain such as toothache, myalgia, neuralgia, and primary dysmenorrhea (menstrual cramps).

“It may assist with maintaining functional stability during temporary episodes of high symptomatic burden.”

The combination is applied in addressing conditions where symptoms create noticeable interference with daily functioning. By helping to ease the overall symptom load, it supports general well-being during symptomatic phases.

Quick Fact: Relief for Acute Discomfort
Symptom Domains Targeted Pain, Fever, and associated Fatigue
Intensity Mild to Moderate Intensity Pain
Core Benefit Supportive symptomatic management

Regulatory References

  1. DailyMed Label for CITRAMON
Advertisements

Eligibility and Restrictions for Use

The use of Цитрамон-Боримед (Acetaminophen, Aspirin, Caffeine) is strictly defined by regulatory eligibility criteria focusing on patient safety and contraindications to its components. The medicine is contraindicated in specific high-risk populations.

Contraindicated Populations

  • Children and Teenagers with Viral Illness: Absolute contraindication due to the risk of Reye’s syndrome associated with the Aspirin component.
  • Late-Stage Pregnancy: Prohibited for women at 20 weeks gestation or later due to potential fetal harm from the NSAID component.
  • Severe Organ Dysfunction: Individuals with severe hepatic impairment, severe renal impairment, or active peptic ulcer disease must not use the medicine.
  • Hypersensitivity: Patients with known allergies to Acetaminophen, Aspirin, Caffeine, or other NSAIDs.
  • Concomitant Use: Must not be taken with any other product containing acetaminophen.

Restricted or Conditional Use

Use requires caution in adults age 60 and older, and those with bleeding disorders or chronic cardiac/pulmonary disease. The drug is generally not recommended for women who are breastfeeding or in the first and early second trimesters of pregnancy. Chronic heavy alcohol consumers are also subject to use restriction due to the heightened risk of liver damage.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory profile for this combination medicine is defined by several documented interactions that impose specific co-administration restrictions. All interaction statements reflect formal regulatory warnings.

Formal Contraindications and Toxicity Risks

Co-administration is formally prohibited with other Acetaminophen-containing products to avoid the severe, additive risk of liver toxicity. The medicine is also contraindicated with high-dose Methotrexate, as the Acetylsalicylic Acid component reduces its renal clearance, leading to toxic plasma levels. Due to the Caffeine component, Monoamine Oxidase Inhibitors (MAOIs) and Clozapine are also prohibited, the latter due to inhibited metabolism and increased drug exposure. The use of other systemic Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) should be avoided due to the additive risk of gastrointestinal adverse effects.

Pharmacodynamic and Substance Interactions

The medicine should not be co-administered with Alcohol due to the dual risk of hepatotoxicity from Acetaminophen and gastrointestinal blood loss from Aspirin. Co-use with Anticoagulants (like Warfarin) increases the pharmacodynamic risk of bleeding. The combination may reduce the effectiveness of certain Antihypertensives and antagonize the effects of CNS depressants. Furthermore, the official label mandates that the medicine must be avoided for 24 hours before procedures using Adenosine or Dipyridamole because the Caffeine component interferes with their effect. Caution is noted for patients with Hepatic or Renal Impairment, as these conditions can increase the severity of certain drug-drug interactions.

Advertisements

Mechanism of Action

Dual Action: Enzyme Inhibition and Signal Dampening

This mechanism involves a key ingredient that functions as an inhibitor of cyclooxygenase (COX) enzymes, particularly in the body's periphery. By blocking these enzymes, the drug limits the production of prostaglandins—chemical mediators that amplify nociceptive signals. This primary action initiates a molecular cascade that modulates signaling pathway activity, leading to an attenuation of nociceptive signal transmission within the nervous system.


Central Nervous System Arousal Modulation

Another essential domain involves the antagonism of adenosine receptors in the central nervous system (CNS). By engaging these specific targets, the drug alters signaling dynamics by promoting the release of stimulating neurotransmitters. This influences the regulation of central arousal responses, resulting in increased central neuronal excitability and modulation of central arousal levels.


Vascular Tone Adjustment and Flow Dynamics

The drug's combined components influence the regulation of vascular smooth muscle tone. The balance of effects, including the reduction of certain prostaglandins and the action of the CNS-stimulant component, modifies local blood flow dynamics. This mechanism is relevant when targeted adjustment of the local physiological environment is required, influencing the resulting physiological consequence.

Advertisements

Dosage and Administration Information

The administration of Цитрамон-Боримед is based on protocols defining the appropriate route, quantity, and timing of intake. As a fixed-dose combination, the medicine is intended solely for oral administration in the form of a solid tablet. The usage pattern is intermittent, characterized by a specific frequency and a constraint on the total dose that can be taken over time.

Standardized Dosing Regimen

The typical unit dose established for adults and adolescents is one tablet. However, the provided instructions permit a maximum single dose of two tablets. Use is subject to a strict time-separation requirement: a minimum interval of 6 to 8 hours must elapse between any two drug intakes to prevent excessive cumulative exposure to the active components. This structured timing ensures the components are administered within established therapeutic bounds.

The overall usage protocol is defined by an absolute ceiling for daily intake. The maximum total daily dose that should not be exceeded within a 24-hour period is four tablets. This medicine is designated for short-term use only, consistent with its general role in acute symptomatic relief.

Administration Rules by Population and Context

This specific dosing regimen is approved for use by adults and children over 15 years of age. No specific instructions regarding mandatory preparation, such as dilution or crushing, are provided, as the medicine is an immediate-release oral tablet. The parameters do not mandate consumption with or without food. These documented parameters define the approach to using the medicine.

Advertisements

Recent Clinical Evidence

Overview of Clinical Research

Clinical evidence for this fixed-dose combination, which contains Acetylsalicylic Acid (Aspirin), Paracetamol (Acetaminophen), and Caffeine, focuses primarily on its use in managing acute pain, particularly headaches.

Randomized controlled trials (RCTs) have examined the efficacy and tolerability of this triple combination compared to its individual components and placebo across various pain models.


Efficacy and Pain Relief Findings

  • Headache and Migraine: Multiple studies and meta-analyses support the combination's use in the treatment of acute episodic tension-type headache and migraine. Findings suggest that the triple combination is associated with a greater proportion of participants achieving pain relief compared to the use of aspirin or paracetamol alone.
  • Role of Caffeine: Research suggests that caffeine, when added to standard analgesics, acts as an adjuvant (helper agent). This addition is associated with a statistically significant increase in the proportion of participants who report a good level of pain relief in various acute pain conditions.
  • Onset and Duration: Some clinical trials have reported that the addition of caffeine may accelerate the absorption of paracetamol, which may contribute to a quicker time to pain relief.

Safety and Tolerability

The combination, when taken occasionally at recommended doses, is generally considered well-tolerated in studies of acute pain. The adverse event profile reflects the known effects of the individual components, with common reported events including nervousness, nausea, and abdominal discomfort due to the caffeine component, and typical gastrointestinal risks associated with Aspirin.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Цитрамон-Боримед (FAQ)

Q: What is the approved minimum age for taking Цитрамон-Боримед?

According to official regulatory documents, this medicine is approved for use by adults and children over 15 years of age. The medicine is formally prohibited for use by younger children and teenagers recovering from a viral illness due to the established risk of Reye's syndrome.

Q: How long does it usually take for Цитрамон-Боримед to start working?

A specific time range for onset of action is not always provided in official drug information. However, clinical research has suggested that the inclusion of caffeine may accelerate the absorption of one of the pain-relieving components. This acceleration may be associated with a more timely onset of pain relief, according to research themes.

Q: How long does the effect of Цитрамон-Боримед last after taking a dose?

Regulatory protocols define a minimum time interval that must pass between any two doses. This interval is required to manage the cumulative exposure of the active components within safe limits.

Q: Can I take Цитрамон-Боримед if I have chronic stomach problems or an upset stomach?

The medicine is contraindicated (should not be used) if you have active peptic ulcer disease or a history of serious gastrointestinal bleeding. For general stomach upset, common side effects include dyspepsia (indigestion) and abdominal pain. Information regarding the full contraindications is available in the official product information for individuals with existing stomach conditions.

Q: Is taking Цитрамон-Боримед permitted while breastfeeding?

Official eligibility criteria categorize the use of this medicine during breastfeeding as restricted. Due to the potential for the components to pass into breast milk, the drug is generally not recommended for women who are breastfeeding.

Q: Should I take Цитрамон-Боримед with food or on an empty stomach?

The regulatory label reviewed does not mandate consumption with or without food. Users should adhere to the prescribed dosing interval.

Q: Can Цитрамон-Боримед cause drowsiness or insomnia?

Official documents list insomnia (difficulty sleeping) and nervousness as common adverse reactions. The caffeine component works by influencing central arousal responses. Therefore, sleep disturbances are a recognized possible effect documented in the safety profile.

Q: Is Цитрамон-Боримед used for reducing fever?

Yes, the fundamental purpose of this medicine is to provide effective symptomatic relief. It is classified as an analgesic-antipyretic combination, meaning it is used for both analgesia (pain relief) and antipyresis (fever reduction).

Q: Is there any information about the influence of Цитрамон-Боримед on the liver or kidneys?

Official safety warnings highlight the risk of severe hepatotoxicity (liver damage) due to the Acetaminophen component. The medicine is contraindicated in individuals with severe hepatic (liver) or severe renal (kidney) impairment.

Q: What does the phrase 'used for symptomatic relief' mean?

Symptomatic relief refers to managing the symptoms of an illness, suchc as pain or fever, rather than treating the underlying condition that causes them. The medicine is designed to make the patient feel more comfortable while the body addresses the primary cause of discomfort.

Q: Can Цитрамон-Боримед cause heartburn or an upset stomach?

Yes, common side effects documented in the official safety profile include dyspepsia, which is the clinical term for indigestion or upset stomach, as well as abdominal pain. These effects are linked to the known safety profile of the combination drug's active ingredients.

Q: Does Цитрамон-Боримед affect concentration or attention span?

The official side effect list includes dizziness and nervousness as common reactions. Furthermore, one of the medicine's components works by influencing the regulation of central arousal responses, which can affect alertness and concentration.

Q: Is it true that Цитрамон-Боримед helps with all types of headache?

Clinical trials and official indications support the medicine's use for acute episodic tension-type headache and migraine. However, official documents do not state that it is effective or indicated for every possible type of headache.

Q: Why is there an instruction limiting the duration of use?

This combination is designated for short-term use only. Official documents explicitly warn that using the medicine for 10 or more days per month may lead to a condition known as Medication Overuse Headache (MOH).

Q: What should people with high blood pressure know about taking Цитрамон-Боримед?

The medicine requires caution in patients with chronic cardiac disease. Additionally, official interaction warnings state that components of this drug may reduce the effectiveness of certain antihypertensive (blood pressure lowering) medications.

Q: Can Цитрамон-Боримед affect the ability to drive a car?

Official safety warnings advise that if effects such as dizziness occur, the ability to operate a motor vehicle or heavy machinery may be affected.

Q: Why is 'tremor' sometimes felt after taking Цитрамон-Боримед?

The medicine contains caffeine, which is a stimulant known to cause increased central nervous system excitability. For caffeine-containing products, official documents may indicate trembling or tremors as a possible effect related to its stimulant properties.

Q: Can people with asthma take Цитрамон-Боримед?

The medicine is contraindicated for patients with a known hypersensitivity (allergy) to Aspirin or other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). The official contraindications should be reviewed, particularly concerning known hypersensitivity to Aspirin or other NSAIDs.

Q: Can Цитрамон-Боримед be used for toothache relief?

Yes, official labeling documents confirm that the medicine is effective for treating mild to moderate intensity pain. This pain relief indication includes uses such as toothache.

Q: Are there any colorants or additives in the composition of Цитрамон-Боримед?

The medicine contains several inactive ingredients, also known as additives or excipients. These include compounds such as Cocoa, Citric acid monohydrate, Potato starch, Talc, and Stearic acid, which are listed in official product information.

Q: Can I take Цитрамон-Боримед if I am on a sugar-restricted diet?

The official inactive ingredients list includes compounds such as Citric acid monohydrate and potato starch. Common sugars (like sucrose) are not specified in the active or inactive components of the formulation provided.

Q: How does Цитрамон-Боримед differ from Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)?

Цитрамон-Боримед is classified as an Analgesic-Antipyretic Combination, meaning it contains several active compounds. It does include an NSAID (Acetylsalicylic Acid/Aspirin) but combines it with Acetaminophen and Caffeine, giving it multiple mechanisms of action.

Q: Is Цитрамон-Боримед used for relieving menstrual pain?

Yes, official labeling documents indicate that the medicine is effective for treating mild to moderate intensity pain. This includes specific uses such as menalgia and algodismenorrhea, which are medical terms for menstrual pain.

Advertisements

How should Цитрамон-Боримед be stored and disposed of?

Official Storage and Disposal Requirements

Storage and handling of Цитрамон-Боримед tablets must follow specific regulatory conditions to maintain product stability and integrity. The medicine must be stored at a temperature not exceeding 25°C (77°F), placing it under controlled room temperature conditions.

Storage Requirement Specification
Temperature Do not exceed 25°C (77°F)
Protection Protect from moisture and store in a dry place
Packaging Store in the original container
Child Safety Keep out of the sight and reach of children

Failure to protect the tablets from excessive heat or moisture can compromise their quality. Unused or expired tablets must be disposed of according to local pharmaceutical waste regulations. Do not discard the medicine into household trash or wastewater to protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Цитрамон-Боримед found in:

A-Z Index: